Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(3)H-dehydroepiandrosterone + NAD(P)+
?
-
-
-
-
?
(4-methyl)zymosterone + NADPH + H+
(4-methyl)zymosterol + NADP+
16alpha-hydroxy-dehydroepiandrosterone + NADH + H+
?
-
-
-
-
?
16beta-hydroxy-dehydroepiandrosterone + NADH + H+
?
-
-
-
-
?
17alpha-hydroxypregnenolone + NADH + H+
17alpha-hydroxyprogesterone + NAD+
-
-
-
-
?
17beta-hydroxy-5alpha-androstan-3-one + NADPH
5alpha-androstane-3beta,17beta-diol + NADP+
2 17beta-hydroxy-5alpha-androstan-3-one + 2 NADPH + 2 H+
5alpha-androstane-3beta,17beta-diol + 5alpha-androstane-3alpha,17beta-diol + 2 NADP+
24-ethylidenelophenone + NADPH
24-ethylidenelophenol + NADP+
-
oxidation: poor
-
r
24-methylenecycloartanone + NADPH
24-methylenecycloartanol + NADP+
-
7% compared with cholest-7-en-3-one, DELTA7-cholestenone
-
ir
24-methylenelophenone + NADPH
24-methylenelophenol + NADP+
-
35% compared with cholest-7-en-3-one, DELTA7-cholestenone
-
?
24-methylenepollinastanone + NADPH + acetate
24-methylenepollinastanol + NADP+
-
70% compared with cholest-7-en-3-one, DELTA7-cholestenone
-
?
24RS-dihydrocycloeucalenone + NADPH
24RS-dihydrocycloeucalenol + NADP+
-
53% compared with cholest-7-en-3-one, DELTA7-cholestenone
-
?
3-keto-5alpha-androstane steroids + NADPH
3beta-hydroxy-5alpha-androstane steroids + NADP+
-
-
-
ir
3-oxocholic acid + NAD(P)H + H+
cholic acid + NAD(P)+
10.3% of the activity compared to the substrate isodeoxycholic acid
-
-
r
3-oxodeoxycholic acid + NAD(P)H + H+
isodeoxycholic acid + NAD(P)+
55.2% of the activity compared to the substrate isodeoxycholic acid
-
-
r
3alpha-androstanediol + NAD+
5alpha-dihydrotestosterone + NADH
-
-
-
-
?
3alpha-androstanediol + NAD+
? + NADH
AKR1C2 and AKR1C4 act as 3alpha-hydroxysteroid oxidase, AKR1C3 predominantly acts as 17beta-hydroxysteroid oxidase catalyzing the conversion of 3alpha-diol to androsterone, negligible activity with the 3beta-androstanediol
-
-
?
4,4-gem-dimethyl-5alpha-cholest-7-en-3-one + NADPH
4,4-gem-dimethyl-5alpha-cholest-7-en-3beta-ol + NADP+
4alpha-methyl-5alpha-cholest-7-en-3-one + NADPH
4alpha-methyl-5alpha-cholest-7-en-3beta-ol + NADP+
-
best substrate, reduction consistently about two times greater for monosubstituted steroid
-
?
4alpha-methylfecosterone + NADPH + H+
4alpha-methylfecosterol + NADP+
-
-
4alpha-methylfecosterol is further converted to ergosterol
-
?
4alpha-methylzymosterol + NADP+
3-dehydro-4-methylzymosterol + NADPH + H+
-
-
-
-
?
4beta-methyl-28-nor-24RS-dihydrocycloeucalenone + NADPH
4beta-methyl-28-nor-24RS-dihydrocycloeucalenol + NADP+
-
27% compared with cholest-7-en-3-one, DELTA7-cholestenone
-
?
5-androstene-3,17-dione + NAD+
dehydroepiandrosterone + NADH + H+
-
-
-
-
?
5alpha-androstan-3,17-dione + NADPH + H+
5alpha-androstan-3beta-ol-17-one + NADP+
-
-
-
-
r
5alpha-androstane-3,17-dione + NADPH
epi-androsterone + NADP+
5alpha-dihydrotestosterone + NADPH + H+
3beta,17beta-dihydroxy-5alpha-androstane + NADP+
-
-
-
-
r
5alpha-dihydrotestosterone + NADPH + H+
5alpha-androstan-3alpha,17beta-diol + NADP+
5alpha-dihydrotestosterone + NADPH + H+
5alpha-androstan-3beta,17beta-diol + NADP+
i.e. DHT, reductive 3beta-HSD activity of AKR1C1 yielding the 3beta,17-diol, preferred reaction
-
-
?
5alpha-pregnan-3,20-dione + NADPH + H+
5alpha-pregnane-3beta-ol-20-one + NADP+
-
-
-
-
r
5alpha-pregnane-21-ol-3,20-dione + NADPH + H+
5alpha-pregnane-3beta,21-diol-20-one + NADP+
-
-
-
-
r
5beta-androstan-3,17-dione + NADPH + H+
5beta-androstan-3beta-ol-17-one + NADP+
-
-
-
-
r
5beta-androstan-3beta-ol-17-one + NADP+
5beta-androstan-3,17-dione + NADPH + H+
-
-
-
-
r
5beta-androstane-3beta,17beta-diol + NADP+
5beta-androstane-17beta-ol-3-one + NADPH + H+
-
-
-
-
r
5beta-cholanic acid-3,7-dione + NADPH + H+
5beta-cholanic acid-3beta-ol-7-one + NADP+
-
-
-
-
r
5beta-dihydrocorticosterone + NADPH + H+
(3beta,5beta,11beta)-3,11,21-trihydroxypregnan-20-one + NADP+
-
-
-
-
r
5beta-dihydrocortisone + NADPH + H+
?
-
-
-
-
r
5beta-dihydrotestosterone + NADPH + H+
3beta,17beta-dihydroxy-5beta-androstane + NADP+
-
-
-
-
r
5beta-hydroxy-5beta cholanic acid + NADP+
3-oxo-5-beta-cholanic acid + NADPH + H+
-
-
-
-
r
5beta-pregnan-3,20-dione + NADPH + H+
5beta-pregnane-3beta-ol-20-one + NADP+
-
-
-
-
r
5beta-pregnane-20-ol-3-one + NADPH + H+
5beta-pregnane-3beta,20-diol + NADP+
-
-
-
-
r
5beta-pregnane-21-ol-3,20-dione + NADPH + H+
5beta-pregnane-3beta,21-diol-20-one + NADP+
-
-
-
-
r
5beta-pregnane-3beta,20alpha-diol + NADP+
5beta-pregnane-20alpha-ol-3-one + NADPH + H+
-
-
-
-
r
5beta-pregnane-3beta,20beta-diol + NADP+
5beta-pregnane-20beta-ol-3-one + NADPH + H+
-
-
-
-
r
5beta-pregnane-3beta,21-diol-20-one + NADP+
5beta-pregnane-21-ol-3,20-dione + NADPH + H+
-
-
-
-
r
5beta-pregnane-3beta-ol-20-one + NADP+
5beta-pregnan-3,20-dione + NADPH + H+
-
-
-
-
r
androstenedione + NAD(P)H
?
-
-
-
-
?
androstenone + NAD(P)H + H+
5alpha-androst-16-en-3beta-ol + NAD(P)+
-
-
-
-
?
avenastenone + NADPH
avenasterol + NADP+
-
more than 72% compared with cholest-7-en-3-one, DELTA7-cholestenone
-
?
chenodeoxycholic acid + NAD(P)+
3-oxo-chenodeoxycholic acid + NAD(P)H + H+
11.7% of the activity compared to the substrate isodeoxycholic acid
-
-
r
cholest-7-en-3-one + NADPH
3beta-hydroxy-cholest-7-ene + NADP+
-
DELTA7-cholestenone, best substrate
DELTA7-cholesterol
ir
cholestanone + NADPH
cholestanol + NADP+
-
57% compared with cholest-7-en-3-one, DELTA7-cholestenone
-
?
cholic acid + NAD(P)+
3-oxo-cholic acid + NAD(P)H + H+
12.7% of the activity compared to the substrate isodeoxycholic acid
-
-
r
cycloartenone + NADPH
cycloartenol + NADP+
-
7% compared with cholest-7-en-3-one, DELTA7-cholestenone
-
ir
cycloeucalenone + NADPH + H+
cycloeucalenol + NADP+
cyclolaudenone + NADPH
cyclolaudenol + NADP+
-
10% compared with cholest-7-en-3-one, DELTA7-cholestenone
-
?
dehydroepiandrosterone + NAD+
androstenedione + NADH + H+
-
-
-
?
dehydroepiandrosterone + NADH + H+
5-androstene-3,17-dione + NAD+
-
-
-
-
?
dehydrolithocholic acid + NADPH + H+
?
-
-
-
-
r
DELTA7-chondrillastenone + NADPH
DELTA7-chondrillasterol + NADP+
deoxycholic acid + NAD(P)+
3-oxo-deoxycholic acid + NAD(P)H + H+
22.4% of the activity compared to the substrate isodeoxycholic acid
-
-
r
dihydrotestosterone + NADPH + H+
5alpha-androstane-3beta,17beta-diol + NADP+
farnesol + NADP+
farnesal + NADPH + H+
-
-
-
-
?
fecosterone + NADPH + H+
fecosterol + NADP+
-
-
-
-
?
geranylgeraniol + NADP+
geranylgeranial + NADPH + H+
-
-
-
-
?
glycochenodeoxycholic acid + NAD(P)+
? + NAD(P)H + H+
13.2% of the activity compared to the substrate isodeoxycholic acid
-
-
r
glycocholic acid + NAD(P)+
? + NAD(P)H + H+
12.4% of the activity compared to the substrate isodeoxycholic acid
-
-
r
glycodeoxycholic acid + NAD(P)+
? + NAD(P)H + H+
20.6% of the activity compared to the substrate isodeoxycholic acid
-
-
r
isodeoxycholic acid + NADP+
3-oxodeoxycholic acid + NADPH + H+
-
-
-
r
isolithocholic acid + NADP+
? + NADPH + H+
-
-
-
-
r
methylglyoxal + NADP+
? + NADPH + H+
-
-
-
-
?
obtusifolione + NADPH
obtusifoliol + NADP+
pregnenolone + NADH + H+
progesterone + NAD+
-
-
-
-
?
progesterone + NADPH
pregn-4-ene-20alpha-ol-3-one + NADP+
i.e. pregn-4-ene-3,20-dione
-
-
?
progesterone + NADPH + H+
4-pregnen-3beta-ol-20-one + NADP+
pyridine-3-aldehyde + NADP+
pyridin-3-ylmethanol + NADPH + H+
-
-
-
-
?
spinastenone + NADPH
spinasterol + NADP+
-
32% compared with cholest-7-en-3-one, DELTA7-cholestenone
-
?
taurochenodeoxycholic acid + NAD(P)+
? + NAD(P)H + H+
11.5% of the activity compared to the substrate isodeoxycholic acid
-
-
r
taurocholic acid + NAD(P)+
? + NAD(P)H + H+
11.5% of the activity compared to the substrate isodeoxycholic acid
-
-
r
taurodeoxychloic acid + NAD(P)+
? + NAD(P)H + H+
21.8% of the activity compared to the substrate isodeoxycholic acid
-
-
r
zymosterone + NADPH
zymosterol + NADP+
[7alpha,17alpha]-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one + NADPH
[7alpha,17alpha]-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-ol + NADP+
additional information
?
-
(4-methyl)zymosterone + NADPH + H+
(4-methyl)zymosterol + NADP+
-
-
-
?
(4-methyl)zymosterone + NADPH + H+
(4-methyl)zymosterol + NADP+
cholesterol pathway
-
-
?
17beta-hydroxy-5alpha-androstan-3-one + NADPH
5alpha-androstane-3beta,17beta-diol + NADP+
-
5alpha-dihydrotestosterone
androstanediol, 5alpha-androstane-3alpha,17beta-diol or 5alpha-androstane-3beta,17beta-diol
?
17beta-hydroxy-5alpha-androstan-3-one + NADPH
5alpha-androstane-3beta,17beta-diol + NADP+
-
DHT
androstanediol, 5alpha-androstane-3alpha,17beta-diol or 5alpha-androstane-3beta,17beta-diol
?
17beta-hydroxy-5alpha-androstan-3-one + NADPH
5alpha-androstane-3beta,17beta-diol + NADP+
-
dihydrotestosterone
androstanediol, 5alpha-androstane-3alpha,17beta-diol or 5alpha-androstane-3beta,17beta-diol
?
17beta-hydroxy-5alpha-androstan-3-one + NADPH
5alpha-androstane-3beta,17beta-diol + NADP+
-
5alpha-dihydrotestosterone
androstanediol, corresponding 3beta-hydroxysteroid
ir
17beta-hydroxy-5alpha-androstan-3-one + NADPH
5alpha-androstane-3beta,17beta-diol + NADP+
-
DHT
androstanediol, corresponding 3beta-hydroxysteroid
ir
17beta-hydroxy-5alpha-androstan-3-one + NADPH
5alpha-androstane-3beta,17beta-diol + NADP+
-
dihydrotestosterone
androstanediol, corresponding 3beta-hydroxysteroid
ir
2 17beta-hydroxy-5alpha-androstan-3-one + 2 NADPH + 2 H+
5alpha-androstane-3beta,17beta-diol + 5alpha-androstane-3alpha,17beta-diol + 2 NADP+
-
the rates of 3alpha-diol versus 3beta-diol formation varies significantly among the isoforms. AKR1C1 predominantly catalyzes the formation of 3beta-diol, whereas AKR1C2 and AKR1C4 predominantly catalyze the formation of 3alpha-diol. AKR1C3 shows relatively low reductive activity towards 17beta-hydroxy-5alpha-androstan-3-one, in which 3alpha-diol and 3beta-diol is formed in almost equal amounts
-
?
2 17beta-hydroxy-5alpha-androstan-3-one + 2 NADPH + 2 H+
5alpha-androstane-3beta,17beta-diol + 5alpha-androstane-3alpha,17beta-diol + 2 NADP+
AKR1cs are a source of beta-tetrahydrosteroids. This is of physiological significance because the formation of 3beta-diol in contrast to 3alpha-diol is virtually irreversible, the 3beta-diol is a pro-apoptotic ligand for estrogen receptor beta, and 3beta-tetrahydrosteroids act as gamma-aminobutyric acid type A receptor antagonists
-
-
?
4,4-gem-dimethyl-5alpha-cholest-7-en-3-one + NADPH
4,4-gem-dimethyl-5alpha-cholest-7-en-3beta-ol + NADP+
-
-
-
?
4,4-gem-dimethyl-5alpha-cholest-7-en-3-one + NADPH
4,4-gem-dimethyl-5alpha-cholest-7-en-3beta-ol + NADP+
-
-
-
?
5alpha-androstane-3,17-dione + NADPH
epi-androsterone + NADP+
-
3-ketosteroid reductase activity of the human 3(alpha-beta)-hydroxysteroid epimerase, stereoselective reduction
epi-ADT
?
5alpha-androstane-3,17-dione + NADPH
epi-androsterone + NADP+
-
5alpha-dione
epi-ADT
?
5alpha-androstane-3,17-dione + NADPH
epi-androsterone + NADP+
-
A-dione
-
-
ir
5alpha-dihydrotestosterone + NADPH + H+
5alpha-androstan-3alpha,17beta-diol + NADP+
-
-
-
-
?
5alpha-dihydrotestosterone + NADPH + H+
5alpha-androstan-3alpha,17beta-diol + NADP+
-
in prostate cells AKR1C2 acts as a 3-ketosteroid reductase to eliminate 5alpha-dihydrotestosterone and prevents activation of androgen receptor. AKR1C2 does not act as an oxidase due to either potent product inhibition by NADPH or because it cannot surmount the oxidative 17beta-hydroxysteroid dehydrogenase present. AKR1C2 is not a source of 5alpha-dihydrotestosterone in PC-3 cells
-
-
?
5alpha-dihydrotestosterone + NADPH + H+
5alpha-androstan-3alpha,17beta-diol + NADP+
i.e. DHT, reductive 3alpha-HSD activity of AKR1C1 yielding the 3alpha,17-diol, low activity
-
-
?
cycloeucalenone + NADPH + H+
cycloeucalenol + NADP+
-
putative endogenous substrate for sterone reductase
reverse oxidation: about 35% of forward reductase rate, 17-(4-isopropyl-1-methyl-pent-4-enyl)-4,13,14-trimethyl-tetradecahydro-cyclopropa[9,10]cyclopenta[a]phenanthren-3beta-ol
r
cycloeucalenone + NADPH + H+
cycloeucalenol + NADP+
-
68% compared with cholest-7-en-3-one, DELTA7-cholestenone
reverse oxidation: about 35% of forward reductase rate, 17-(4-isopropyl-1-methyl-pent-4-enyl)-4,13,14-trimethyl-tetradecahydro-cyclopropa[9,10]cyclopenta[a]phenanthren-3beta-ol
r
DELTA7-chondrillastenone + NADPH
DELTA7-chondrillasterol + NADP+
-
70% compared with cholest-7-en-3-one, DELTA7-cholestenone
17-(4-ethyl-1,5-dimethyl-hex-2-enyl)-10,13-dimethyl-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3beta-ol
?
DELTA7-chondrillastenone + NADPH
DELTA7-chondrillasterol + NADP+
-
5alpha,28beta(H)-stigmasta-7,22-dien-3-one
17-(4-ethyl-1,5-dimethyl-hex-2-enyl)-10,13-dimethyl-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3beta-ol
?
dihydrotestosterone + NADPH + H+
5alpha-androstane-3beta,17beta-diol + NADP+
-
-
-
?
dihydrotestosterone + NADPH + H+
5alpha-androstane-3beta,17beta-diol + NADP+
steroid hormone pathway
-
-
?
obtusifolione + NADPH
obtusifoliol + NADP+
-
4,14-dimethyl-ergosta-8,24(28)-dien-3-one
4,14-dimethyl-ergosta-8,24(28)-dien-3-ol
?
obtusifolione + NADPH
obtusifoliol + NADP+
-
43% compared with cholest-7-en-3-one, DELTA7-cholestenone
4,14-dimethyl-ergosta-8,24(28)-dien-3-ol
?
obtusifolione + NADPH
obtusifoliol + NADP+
-
4,14-dimethyl-ergosta-8,24(28)-dien-3-one
4,14-dimethyl-ergosta-8,24(28)-dien-3-ol
?
progesterone + NADPH + H+
4-pregnen-3beta-ol-20-one + NADP+
-
-
-
?
progesterone + NADPH + H+
4-pregnen-3beta-ol-20-one + NADP+
steroid hormone pathway
-
-
?
zymosterone + NADPH
zymosterol + NADP+
-
-
-
-
?
zymosterone + NADPH
zymosterol + NADP+
-
-
-
-
?
[7alpha,17alpha]-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one + NADPH
[7alpha,17alpha]-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-ol + NADP+
i.e. tibolone, a synthetic hormone
-
-
?
[7alpha,17alpha]-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one + NADPH
[7alpha,17alpha]-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-ol + NADP+
-
i.e. tibolone, a synthetic hormone
reaction product determination and analysis
-
?
additional information
?
-
-
substrate for 3-ketoreductase in the first sterol C-4 demethylation cycle is 4alpha-methylfecosterone, whereas that for the second C-4 demethylation cycle is fecosterone
-
-
?
additional information
?
-
-
NADPH-dependent 3-ketosteroid reductase catalyzes reduction of the 3-keto group to a 3beta-hydroxyl group
-
-
?
additional information
?
-
-
enzyme of sterol, ergosterol, biosynthesis, enzyme catalyzes last step in demethylation at C-4
-
-
?
additional information
?
-
-
3-ketosteroid reductase activity of the human 3(alpha-beta)-hydroxysteroid epimerase catalyzes reduction of 3-ketosteroids to form 3beta-hydroxysteroids
-
-
?
additional information
?
-
-
HSD17B7 participates in postsqualene cholesterol biosynthesis, HSD17B7 is a novel candidate for inborn errors of cholesterol metabolism
-
-
?
additional information
?
-
-
tibolone is used to treat climacteric symptoms and prevent osteoporosis, it exerts tissue-selective effects via site-specific metabolism into 3alpha- and 3beta-hydroxymetabolites and a DELTA4-isomer, In Hep-G2 cell cytosol and intact cells tibolone is exclusively reduced to 3beta-hydroxytibolone, tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily, overview
-
-
?
additional information
?
-
AKR1C1 is a cytosolic hydroxysteroid dehydrogenase, that reduces 3-ketosteroids and 20-ketosteroids, overview, molecular docking simulations with generation of docking targets, overview
-
-
?
additional information
?
-
-
AKR1C1 is a cytosolic hydroxysteroid dehydrogenase, that reduces 3-ketosteroids and 20-ketosteroids, overview, molecular docking simulations with generation of docking targets, overview
-
-
?
additional information
?
-
-
comparison of substrate specificity and enantioselectivity of AKR1C isozymes, overview
-
-
?
additional information
?
-
-
both isoforms of the enzyme catalyze the conversion of 3beta-hydroxy-5-ene-steroids (dehydroepiandrosterone, 17alpha-hydroxypregnenolone, pregnenolone) to 3-oxo-4-ene-steroids (androstenedione, 17alpha-hydroxyprogestrone, progesterone) on a single, dimeric protein containing both enzyme activities
-
-
?
additional information
?
-
-
enzyme might form complexes with other proteins, including possibly DNA-binding proteins, under low ionic strength conditions
-
-
?
additional information
?
-
-
HSD17B7 participates in postsqualene cholesterol biosynthesis
-
-
?
additional information
?
-
-
the enzyme, termed AKR1B19, acts not only as a reductase for reactive carbonyl compounds derived from lipid peroxidation like AR-like proteins of other species, but also as a superior reductive 3beta-HSD for 3-keto-5alpha/beta-dihydro-C19/C21/C24-steroids
-
-
?
additional information
?
-
-
substrate specificity of the bifunctional enzyme, for carbonyl compounds and steroids, overview. No reductase activity is observed for 17- and 20-ketosteroids, DELTA4-3-ketosteroids (testosterone, 4-androstene-3,17-dione and progesterone), and prostaglandins (D2, E2, and A1). In the reverse reaction, the enzyme oxidizes 3beta-hydroxy-5alpha/beta-dihydrosteroids, but shows no significant dehydrogenase activity for DELTA5-3beta-hydroxysteroids (dehydroepiandrosterone, pregnenolone, and 5-pregnene-3beta,20alpha-diol) and 3alpha-hydroxysteroids (5alpha/beta-androstan-3alpha-ol-17-ones, 5alpha/beta-androstane-3alpha,17beta-diols, 5alpha/beta-pregnan-3alpha-ol-20-ones and lithocholic acid). The reactivity towards all-trans-retinal of AKR1B19 is low
-
-
?
additional information
?
-
-
substrate specificity
-
-
?
additional information
?
-
-
substrate specificity
-
-
?
additional information
?
-
-
catalyzes the conversion of 3-keto-saturated steroids such as 5alpha-dihydrotestosterone, DHT, and 5alpha-androstane-3,17-dione, A-dione, into less active steroids
-
-
?
additional information
?
-
-
sterol substrate specificity with 4alpha-monomethyl- and 4,4-dimethyl-3-ketosteroids
-
-
?
additional information
?
-
-
catalyzes NADPH-dependent reduction of 3-ketosteroid intermediates, 4-methyl sterol intermediates, of cholesterol biosynthesis from lanosterol, regenerates 3beta-hydroxy sterol
-
-
?
additional information
?
-
-
enzyme of cholesterol biosynthesis
-
-
?
additional information
?
-
-
enzyme of cholesterol biosynthesis
-
-
?
additional information
?
-
-
enzyme of mevalonate pathway for biosynthesis of cholesterol from lanosterol
-
-
?
additional information
?
-
-
involved in the 10-step oxidative removal of the 4-gem-dimethyl group of sterols
-
-
?
additional information
?
-
-
step of biosynthesis of hormonal steroids
-
-
?
additional information
?
-
-
the enzyme is also involved in synthesis of estradiol and estrone, neurosteroids paly a role in brain develkopment and in stimulation and control of song function
-
-
?
additional information
?
-
-
substrate specificity
-
-
?
additional information
?
-
-
coprostanol: not a substrate
-
-
?
additional information
?
-
-
3-keto reducing enzyme is specific for a 5alpha, trans A/B ring junction in the sterone substrate, as found in all sterol biosynthesis intermediates
-
-
?
additional information
?
-
-
4alpha-methyl-9beta,19-cyclo-C30-sterones and 4-desmethyl-DELTA7-C27-sterones or C30-sterones are preferentially reduced, 4,4-dimethyl-C30-sterones or C31-sterones react poorly. Produces stereoselectively corresponding 3beta-alcohol derivatives, no 3alpha-alcohol product is formed
-
-
?
additional information
?
-
-
catalyzes NADPH-dependent C-3 reduction of various sterones to produce stereoselectively the corresponding 3beta-hydroxy derivatives
-
-
?
additional information
?
-
-
constitutive component of microsomal sterol 4-demethylation complex in photosynthetic organism
-
-
?
additional information
?
-
-
enzyme of plant sterol biosynthesis, involved in sterol-4 demethylation, invoves the removal of two methyl groups at C4
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Billheimer, J.T.; Alcorn, M.; Gaylor, J.L.
Solubilization and partial purification of a microsomal 3-ketosteroid reductase of cholesterol biosynthesis
Arch. Biochem. Biophys.
211
430-438
1981
Rattus norvegicus
brenda
Appelkvist, E.L.; Reinhart, M.; Fischer, R.; Billheimer, J.; Dallner, G.
Presence of individual enzymes of cholesterol biosynthesis in rat liver peroxisomes
Arch. Biochem. Biophys.
282
318-325
1990
Rattus norvegicus
brenda
Pascal, S.; Taton, M.; Rahier, A.
Plant sterol biosynthesis: identification of a NADPH dependent sterone reductase involved in sterol-4 demethylation
Arch. Biochem. Biophys.
312
260-271
1994
Zea mays
brenda
Wieland, S.J.; Fox, T.O.
A DNA-binding of mouse kidney 3-ketosteroid reductase: comparison with androgen receptors
Steroids
37
527-538
1981
Mus musculus
brenda
Vanden Bossche, H.; Marichal, P.; Le Jeune, L.; Coene, M.C.; Gorrens, J.; Cools, W.
Effects of itraconazole on cytochrome P-450-dependent sterol 14alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans
Antimicrob. Agents Chemother.
37
2101-2105
1993
Cryptococcus neoformans
brenda
Huang, X.F.; Luu-The, V.
Gene structure, chromosomal localization and analysis of 3-ketosteroid reductase activity of the human 3(alpha->beta)-hydroxysteroid epimerase
Biochim. Biophys. Acta
1520
124-130
2001
Homo sapiens
brenda
De Launoit, Y.; Zhao, H.F.; Belanger, A.; Labrie, F.; Simard, J.
Expression of liver-specific member of the 3beta-hydroxysteroid dehydrogenase family, an isoform possessing an almost exclusive 3-ketosteroid reductase activity
J. Biol. Chem.
267
4513-4517
1992
Rattus norvegicus
brenda
Rizner, T.L.; Lin, H.K.; Peehl, D.M.; Steckelbroeck, S.; Bauman, D.R.; Penning, T.M.
Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells
Endocrinology
144
2922-2932
2003
Homo sapiens
brenda
Steckelbroeck, S.; Jin, Y.; Gopishetty, S.; Oyesanmi, B.; Penning, T.M.
Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action
J. Biol. Chem.
279
10784-10795
2004
Homo sapiens (Q04828), Homo sapiens
brenda
Marijanovic, Z.; Laubner, D.; Moeller, G.; Gege, C.; Husen, B.; Adamski, J.; Breitling, R.
Closing the gap: Identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis
Mol. Endocrinol.
17
1715-1725
2003
Homo sapiens, Mus musculus
brenda
Tam, H.; Schlinger, B.A.
Activities of 3beta-HSD and aromatase in slices of developing and adult zebra finch brain
Gen. Comp. Endocrinol.
150
26-33
2006
Taeniopygia guttata
brenda
Steckelbroeck, S.; Oyesanmi, B.; Jin, Y.; Lee, S.H.; Kloosterboer, H.J.; Penning, T.M.
Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily
J. Pharmacol. Exp. Ther.
316
1300-1309
2006
Homo sapiens
brenda
Jin, Y.; Penning, T.M.
Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences
Steroids
71
380-391
2006
Homo sapiens (Q04828), Homo sapiens
brenda
Taramino, S.; Valachovic, M.; Oliaro-Bosso, S.; Viola, F.; Teske, B.; Bard, M.; Balliano, G.
Interactions of oxidosqualene cyclase (Erg7p) with 3-keto reductase (Erg27p) and other enzymes of sterol biosynthesis in yeast
Biochim. Biophys. Acta
1801
156-162
2010
Saccharomyces cerevisiae
brenda
Taramino, S.; Teske, B.; Oliaro-Bosso, S.; Bard, M.; Balliano, G.
Divergent interactions involving the oxidosqualene cyclase and the steroid-3-ketoreductase in the sterol biosynthetic pathway of mammals and yeasts
Biochim. Biophys. Acta
1801
1232-1237
2010
Homo sapiens (P56937), Homo sapiens, Mus musculus (O88736), Mus musculus
brenda
Mo, C.; Valachovic, M.; Randall, S.K.; Nickels, J.T.; Bard. M.
Protein-protein interactions among C-4 demethylation enzymes involved in yeast sterol biosynthesis
Proc. Natl. Acad. Sci. USA
99
39-44
2002
Saccharomyces cerevisiae
brenda
Endo, S.; Matsunaga, T.; Kumada, S.; Fujimoto, A.; Ohno, S.; El-Kabbani, O.; Hu, D.; Toyooka, N.; Mano, J.; Tajima, K.; Hara, A.
Characterization of rabbit aldose reductase-like protein with 3beta-hydroxysteroid dehydrogenase activity
Arch. Biochem. Biophys.
527
23-30
2012
Oryctolagus cuniculus
brenda
Thomas, J.L.; Mack, V.L.; Sun, J.; Terrell, J.R.; Bucholtz, K.M.
The functions of key residues in the inhibitor, substrate and cofactor sites of human 3beta-hydroxysteroid dehydrogenase type 1 are validated by mutagenesis
J. Steroid Biochem. Mol. Biol.
120
192-199
2010
Homo sapiens
brenda
Debieu, D.; Bach, J.; Montesinos, E.; Fillinger, S.; Leroux, P.
Role of sterol 3-ketoreductase sensitivity in susceptibility to the fungicide fenhexamid in Botrytis cinerea and other phytopathogenic fungi
Pest Manag. Sci.
69
642-651
2013
Botrytis cinerea
brenda
Layer, J.; Barnes, B.; Yamasaki, Y.; Barbuch, R.; Li, L.; Taramino, S.; Balliano, G.; Bard, M.
Characterization of a mutation that results in independence of oxidosqualene cyclase (Erg7) activity from the downstream 3-ketoreductase (Erg27) in the yeast ergosterol biosynthetic pathway
Biochim. Biophys. Acta
1831
361-369
2013
Mus musculus (O88736), Mus musculus
brenda
Ferrante, T.; Barge, A.; Taramino, S.; Oliaro-Bosso, S.; Balliano, G.
4-Methylzymosterone and other intermediates of sterol biosynthesis from yeast mutants engineered in the ERG27 gene encoding 3-ketosteroid reductase
Lipids
51
1103-1113
2016
Saccharomyces cerevisiae (Q12452), Saccharomyces cerevisiae
brenda
Chen, G.; Bai, Y.; Ren, L.; Zhu, D.; Li, Y.; Fang, M.; Al-Kateb, H.; Doran, O.
Metabolism of androstenone, 17beta-estradiol and dihydrotestosterone in primary cultured pig hepatocytes and the role of 3beta-hydroxysteroid dehydrogenase in this process
PLoS ONE
10
e113194
2015
Sus scrofa
brenda
Mythen, S.; Devendran, S.; M�ndez-Garc�a, C.; Cann, I.; Ridlon, J.
Targeted synthesis and characterization of a gene cluster encoding NAD(P)H-dependent 3alpha-, 3beta-, and 12alpha-hydroxysteroid dehydrogenases from Eggerthella CAG 298, a gut metagenomic sequence
Appl. Environ. Microbiol.
84
e02475-17
2018
Eggerthella sp. CAG:298 (R7AF73)
brenda
Ferrante, T.; Adinolfi, S.; DArrigo, G.; Poirier, D.; Daga, M.; Lolli, M.L.; Balliano, G.; Spyrakis, F.; Oliaro-Bosso, S.
Multiple catalytic activities of human 17beta-hydroxysteroid dehydrogenase type 7 respond differently to inhibitors
Biochimie
170
106-117
2020
Homo sapiens (P56937), Homo sapiens
brenda
Rozycka, M.; Kurowska, P.; Grzesiak, M.; Kotula-Balak, M.; Tworzydlo, W.; Rame, C.; Gregoraszczuk, E.; Dupont, J.; Rak, A.
Apelin and apelin receptor at different stages of corpus luteum development and effect of apelin on progesterone secretion and 3beta-hydroxysteroid dehydrogenase (3beta-HSD) in pigs
Anim. Reprod. Sci.
192
251-260
2018
Sus scrofa
brenda
Wang, X.Q.; Aka, J.A.; Li, T.; Xu, D.; Doillon, C.J.; Lin, S.X.
Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78
J. Steroid Biochem. Mol. Biol.
172
188-197
2017
Homo sapiens (P56937)
brenda
Pham, J.H.; Will, C.M.; Mack, V.L.; Halbert, M.; Conner, E.A.; Bucholtz, K.M.; Thomas, J.L.
Structure-function relationships for the selective inhibition of human 3beta-hydroxysteroid dehydrogenase type 1 by a novel androgen analog
J. Steroid Biochem. Mol. Biol.
174
257-264
2017
Homo sapiens (P14060)
brenda
Chang, Y.C.; Lin, C.H.; Lin, J.C.; Cheng, S.P.; Chen, S.N.; Liu, C.L.
Inhibition of 3beta-hydroxysteroid dehydrogenase type 1 suppresses interleukin-6 in breast cancer
J. Surg. Res.
241
8-14
2019
Homo sapiens (P14060)
brenda